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DEBRA BOWEN I SECRETARY OF STATE 
STATE OF CALIFORNIA IELECTIONS 
1500 11th Street, 5th Floor ISacramento, CA 9s8141Tel (916) 657-21661Fax (916) 653-3214 lwww.sos.ca.gov 
May 2,2012 
County Clerk/Registrar of Voters (CC/ROV) Memorandum #12138 
TO: erks/Registrars of Voters and Proponent 
FROM: 
Katherine Montgomery 
Initiative Program Manager 
RE: Initiative: Failure of #1523, Related to Taxes and Controlled 
Substances 
Pursuant to Elections Code section 9030(b), you are hereby notified that the total 
number of signatures for the hereinafter named initiative statute filed with all 
county elections officials is less than 100 percent of the number of qualified 
voters required to find the petition sufficient; therefore, the petition has failed. 
TITLE: 	 TAX ON CONTROLLED SUBSTANCES. INITIATIVE 
STATUTE. 
SUMMARY DATE: 	 November 21 , 2011 
PROPONENT: 	 Robert Pack 
DEBRA BOWEN I SECRETARY OF STATE 
STATE OF CALIFORNIA IELECTIONS 
1500 11th Street. 5th Floor ISacramento. CA 95~h41Tel (916) 657-21661 Fax (916) 6s3-32L4lwww.sos.ca.gov 
November 21, 2011 
County Clerk/Registrar of Voters (CC/ROV) Memorandum #11120 
TO: All County Clerks/Registrars of Voters and Proponent 
FROM: 
Initiative Program Marn\!~er 
RE: Initiative: 1523, Related to Taxes and Controlled Substances 
Pursuant to Elections Code section 9004 (c), we transmit herewith a copy of the 
Title and Summary prepared by the Attorney General on a proposed initiative 
measure entitled : 










TAX ON CONTROLLED SUBSTANCES. 
INITIATIVE STATUTE. 
CIRCULATING AND FILING SCHEDULE 
1. 	 Minimum number of signatures required: .................................................... 504,760 
California Constitution, Article II , Section 8(b) 
2. 	 Official Summary Date: ............................................................ ... Monday, 11/21/11 

3. 	 Petitions Sections: 
a. 	 First day Proponent can circulate Sections for 
signatures (Elections Code § 336) .............. . ......................... Monday, 11121/11 
b. 	Last day Proponent can circulate and file with the county. 
All sections are to be filed at the same time within each 
county. (Elections Codes §§ 9014, 9030(a)) ........................ Thursday, 04/19/12 
c. 	 Last day for county to determine total number of 
signatures affixed to petitions and to transmit total 
to the Secretary of State (Elections Code § 9030(b» ............ Tuesday, 05/01/12 
(If the Proponent files the petition with the county on a date prior to 
04/19/1.2, the county has eight working days from the filing of the petition 
to determine the total number of signatures affixed to the petition and to 
transmit the total to the Secretary of State) (Elections Code § 9030(b).) 
d. 	 Secretary of State determines whether the total number 

of signatures filed with all county clerks/registrars of 

voters meets the minimum number of required signatures 
and notifies the counties .......................... ........ ............ Thursday, 05/10/12" 

e. 	 Last day for county to determine total number of qualified 
voters who signed the petition, and to transm~ certificate 
with a blank copy of the petition to the Secretary of State 
(Elections Code §§ 9030(d)(e)) .............................. .............. Friday, 06/22/12 
* Date varies based on the date of county receipt. 
INITIATIVE #1523 

Circulating and Filing Schedule continued: 

(If Ihe Secrelary of State nolifies Ihe county to determine Ihe number of 
qualified voters who signed Ihe petilion on a date other than 05/10/12 , Ihe 
lasl day is no laler Ihan the thirtieth working day after Ihe counly's receipt 
of notificalion). (Eleclions Code §§ 9030(d)(e).) 
f. 	 If the signalure count is more than 555,236 or less than 
479,522 Ihen the Secretary of Slate certifies the pelition as 
qualified or failed, and nolifies the counties. If the signalure 
counl is between 479,522 and 555,236 inclusive, then the 
Secretary of State notifies the counties using the random 
sampling technique to determine the valid ity of all 
signatures (EC §9030(f)(g); 9031 (a)) .. .. .... .. ............ .. .. ........ Monday, 07/02112" 
g. 	 Last day for county to determine actual number of all qualified 
voters who signed the petition, and to transmij certificate 
with a blank copy of the petition to the Secretary of State. 
(Elections Code §§ 9031 (b)(c)) ............................................ Tuesday, 08114112 
(If the Secretary of State notifies the county to determine the number of 
qualified voters who have signed the petition on a date other than 
07/02112 , the last day is no later than the thirtieth working day after the 
county's receipt of notification.) (Elections Code §§ 9031(b)(c).) 
h. 	 Secretary of State certifies whether the petition has been 
signed by the number of qualified voters required to declare 
the petition sufficient (Elections Code §§ 9031(d), 9033) ... Saturday, 08/18112" 
"'Date varies based on the date of county receipt. 
IMPORTANT POINTS 

• 	 California law prohibils the use of signatures, names and addresses 
gathered on initiative petitions for any purpose other than to qualify the 
initiative measure for the ballot. This means that the petitions cannot be 
used to create or add to mailing lists or similar lists for any purpose, 
including fund raising or requests for support. Any such misuses 
constitutes a crime under California law. Elections Code § 18650; 
Bilofsky v. Deukmejian (1981) 124 Cal.App.3d 825, 177 Cal.Rptr. 621; 
63 Ops.CaI.Atty.Gen. 37 (1980). 
• 	 Please refer to Elections Code §§ 100, 101, 104, 9008, 9009, 9013, 
9021, and 9022 for appropriate format and type consideration in printing, 
typing and otherwise preparing your initiative petition for circulation and 
signatures. Please send a copy of the petition after you have it printed. 
This copy is not for our review or approval, but to supplement our file. 
• 	 Your attention is directed to the campaign disclosure requirements of the 
Political Reform Act of 1974, Government Code section 81000 et seq. 
• 	 When writing or calling state or county elections officials, provide the 
official title of the initiative which was prepared by the Attorney General. 
Use of this title will assist elections officials in referencing the proper file. 
• 	 When a petition is presented to the county elections official for filing by 
someone other than the proponent, the required authorization shall 
include the name or names of the persons filing the petition. 
• 	 When filing the petition with the county elections official, please provide 
a blank petition for elections official use. 
KAMALA D. HARRIS State ofCalifornia 
Attorney General DEPARTMENT OF JUSTICE 
1300 I STREET, SUITE 125 
P.O. BOX 944255 
SACRAMENTO, CA 94244·2550 
Public: ~9 1~ 445·9555 
Telepbone: 91 324-5464 
Facsimile: 916 324-8835 
E-Mail: DawnMcFarland@doj.ca.gQY 
November 21, 2011 
FILED 
The Honorable Debra Bowen In (he office of the Secretary of State of the State of California 
Secretary of State 
Office of the Secretary of State VI'" NOV 21 2011 """I'fl'-
1500 11th Street, 5th Floor 3:4Y!'"" 
. Sacramento, CA 95814 Debra ~ tate 
Attention: Ms. Katherine Montgomery 
ElectioDS Analyst 
Dear Secretary Bowen: 
Pmsuant to Elections Code section 9094. you are hereby notified that on this day we sent our 
title and summary for the following proposed initiative to the proponent: 
• 	 11-0045, "Imposes A Fee On Drug Companies To Fund The CURES Program For Safe 
.Prescribing OfPrescription Narcotics" 
A copy of that title and summary and text of the proposed initiative is enclo~ed. Please . 





Acting Initiative Coordinator 
For 	 KAMALAD. HARRIS 
Attorney General 
DLM: 
cc: 	 Robert Pack, Proponent 
November 21 , 2011 
Initiative 11-0045 
The Attorney General of California has prepared the following title and summary of the chief 
purpose and points of the proposed measure: 
TAXON CONTROLLED SUBSTANCES. INITIATIVE STATUTE. For three years 
beginning January 1, 2013, imposes a tax of$.0025 per pil l upon drug manufacturers and 
importers that make initial saJe ofa Schedule II , III , or IV contro lled substance in California. 
Provides revenue to fund California Department of Justice 's program to monitor prescription and 
di spen~ation of controlled substances, administration costs, outreach, education, and 
investigation of abuses. Requires any person that manufactures Schedule II, III, or IV controlled 
substances in California, or imports them into California, to register with the California 
Department of Justice for purposes of tax compliance. Summary of estimate by Legislative 
Analyst and Director of Finance of fi scal impact on state and local government: Increased state 
revenues of approximately $7 million annually from a new tax on prescription drugs. The 
revenues would be used to increase spending on a prescription drug database maintained 
by DOJ. (11·0045) 
1 1 0 0 4 5 

~CE'VED 
SEP 3 0 2011 
To; INITIATIVE COORDINATOR · 
ATIORNEY GENERAL'S OFFICE 
Office of the Attorney Genera'i 
State of California 
Sept. 20, 2011 
J am requesting that the enclosed proposition be submitted for TItle and Summary for the 2012 election 









September 30, 2011 
California State Ballot Measure / Proposition for 2012 




Proposal for Title and Summary 
SUMMARY 
Imposes a tax on every manufacturer and importer, or other 
person that makes the ~t sale in the state, of a 
Schedule II, III or IV controlled substance, at the rate of 
$0.0025 per pill. Creates a fund to support the Controlled 
Substance Utilizatiori Review and Evaluation System (CURES). 
CHANGES TO EXISTING LAW 
Existing federal law: 
Regulates the manufacture, importation, possession, use, 
and distribution of certain substances, including 
controlled substances. and classifies these substances by 
Schedules based on a criteria which includes potential for 
abuse, currently accepted medical use for.treatment in the 
U.S. , and international treaties. 
Requires the Department ofJustice (DOJ) to maintain CURES 
for electronic monitoring of the prescribing and dispensing 
of Schedule II, .III and lV controlled substances by all 






Requires all practitioners authorized to prescribe or 
dispense these controlled substances to report specified 
information every time these controlled substances are 
prescribed or dispensed. 
This proposition 
Imposes a tax at the rate of $0.0025 per pill included in 
Schedule IT, Ill, or IV upon every manufacturer and 
importer of controlled substances classified as Schedule 
n, m, or IV, or other person that makes the first sale 
in this state ofa Schedule n, m. odV controlled 
substance. 
Requires the State Board ofEqualization to administer and 
collect the tax pursuant to the procedures set forth in the 
Fee Collection Procedures Law. Requires the board to 
deposit all taxes, penalties, and interest collected, less 
refunds and administrative costs, in the CURES Fund, which 
this proposi.tionwould create. 
Requires moneys in the fund, upon appropriation by the 
Legislature, to be allocated to DOJ for the cost of the 
CURES program, as specified. 
Requires aperson that manufactures controlled substances 
classified in Schedule TI, m, or IV in this suite, or 
that impo~ controlled substances classified in Schedule 
II. III. or IV in to this state. to register with DOl to enable the 
departrrient to repOrt specified information to "the board for 
purpo.ses of collecting a tax on those persons. 
DOJ estimates that over 45 million prescriptions are 
written annually, and two billion pills are related to 
those prescriptions. The $0.0025 tax per pill included in 
Schedule II. III. or IV proposed by SB 1071 is estimated by 
DOJ to raise· approximately $5 million in special:fund 
revenues. 
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BACKGROUND AND DISCUSSION 
According to the author, is a'response to the 
steadily worsening prescription drug abuse crisis. The 
author states that prescnption drug abuse ·has serious 
consequences for both abusers and the public. Each year, 
hundreds of people die from prescription drug overdose and 
dozens more are injur.ed or killed by prescription drug 
abusers driving under the influence ofmedication. The 
. author contends that the ".measue" will help to curb prescription 
drug abuse by providing revenues to sustain the Controlled 
Substance Utilization Review and Evaluation System (CURES), 
which is designed to control the misuse, abuse, and 
trafficking of dangerous prescription narcotics. 
It is the author's intent to impose atax on Schedule n. 
III and N drugs that are in the form ofpills, that will 
produce roughly S5 million per year to support the CURES 
progrtun. 
A priority for the use of the funds would be increasing the 
rate at which authorized persons access infonnation from 
he CURES Internet database pertaining to prescribing 
controlled substances, related to patient histories on 

being prescribed controned substances. 

Controlled substances 
Controlled substances are drugs that have a high potential 
for abuse, and are regulated by both state and federal 
governnient. The federal government regulates the 
mannfacture, diStribution, and dispensing of controlled 
substances through the Controlled Substances Act of 1970 
(Act). The Act ranks into five schedules those drugs known 
to have potential for physical or psychological harm, based . 
on three considerations: 1) their potential for abuse; 2) 
their accepted medical use; and, 3) their accepted safety 
under medical supervision. 
Schedule I controlled substances have a high potential for 
abuse and no generally accepted medical use such as heroin, 
LSD and marijuana. Schedule n controlled substances have 
a currently accepted medical use in treatment, or a 
currently accepted medical use with severe restrictions, 
and have a high potential for abuse and psychological or 
physical dependence. Schedule ndrugs can be mkcotics or 
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non·narcotic. Examples of Schedule II controlled 

substances include morphine. methadone. Ritalin, Demerol. 

Dilaudid, Percocet, Percodan, and Oxycontin. Scbedule ill 

and IV drugs include Vicodin, Zanex, Ambien and other 

anti·anxiety drugs that generally have less potential for 

abuse than Schedule II drugs. but are known to be'mixed in 

specific ways to achieve a narCotic-like end product. 

Schedule V dru&,S are available over the counter. ' 

Prescription drug abuse and drug monitoring programs 

Excluding alcohol, prescription drugs are the second mos,t 

commonly abused substance, after marijuana, according to a 

2007 study by the Substance Abuse and Mental Health 

Services Administration. The National Survey on Drug Use 

and Health estimates tbat 20 to 30 percent ofCalifornia's 

drug abusers primarily use prescription drugs, and a 2005 

survey by the Drug Abuse Warning Network'estimates that 

non-medical use ofpharmaceuticals accounted for more than 

half a million emergency room visits in the state. The DOJ 

reports that Valium, ViC<><Jm; and Oxycontin are the most 
prevalent pharmaceutical drugs obtained fraudulently. and 
Vicodin and Oxycontin are the two most abuused phannaceutical 
drugs in the United States. 
Most states use Prescription Drug Monitoring Programs to 
, help regulatory and law enforcement agencies and public 
health officials collect and analyze controlled substance 
prescription data. Statewide databases contain information 
from phannacists and other prescribers on drugs 4ispensed 
in the state. 
According to the National Conference of State Legislatures, 

as oflate 2010, 40 states bad laws establishing tbe 

monitoring programs, and 33 states were operating such 

programs. The programs vary in how they identify and 

investigate potential abuse. Some are reactive, 

hea1th-oriented monitoring programs that' generate reports 

only in response to specific inquiries. 

Other states , . 
identify ,and investigate cases, as well as unsolicited reports 
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when suspicious behavior is detected 
Controlled Substance Utilization Review and Evaluation 

System (CURES) , , ' 

Since 1940, DO] has maintained a state database of 

dispensed prescription drugs with • high potential for 

misuse. This infonnation is currently stored in the CURES 

program, which contains over 100 million entries of . 

controlled substance drugs that have been dispensed in 

California. Each year the CURES program responds to more 

that 60,000 requests from authorized practitioners and 

pharmacists for patient prescription history illfo,rmatlon. 

, In September of 2009, the Attorney General launched the 
Prescription Drug Monitoring Program (PDMP) system allowing , 
pre-registered users, including licensed health care 
. prescribers eligible to prescribe controlled substances, 
pharmacists authorized to dispense controlled substances, 
law enforcement, and regulatory boards, to access ~-time 
patient controlled substance history information through a 
secure website. Prior to adoption of PDM:P, doctors and 
pharmacists had to request information by fax, mail o.r 
phone, and wait days for a response. A $1.1 million 
federal grant and edditionaJ state resources were used to 
develop the new system. Under the systc;m. a registered 
person authorized to prescribe or dispense a controlled 
substance is able t.o instantly look up a new patient's 
controlled s.ubstance history to determine whether the 
patient legitimately needs medication or is doctor 
shopping, the act of visiting several doctors to obtain 
multiple prescriptions for drugs. The system also assists 
. persons authorized to prescribe or dispense controlled 
substances to assure patient safety. . 
In order to obtain access to the system, authprized persons 

must first register with CURES by submitting an application 

and notarized doc~entation including: Drug Eriforcement 

AdminiStration Registration, State Medical License or State 

Phannacy License, and a government issued identification. 

While all persons authorized to prescribe or dispense 
controlled substances must submit information to be entered ' 
into the system, a very smal1 percentage of these persons 
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are availing themselves of the database when it comes to 
checking patient history before a prescription is written 
or dispensed. According to DOl, out of the 185,000 Persons 
authorized to write or dispense controlled. substances. a . 
total of 5,434 have registered to access the database and 
to date, 2,458 have been approved, others m~y be pending 
additional information, notary, documentation, or 
confirmation. 
Dissemination or distribution ofPDMP information to. anyone 
other than the registered user is strictly prohibited. 
Disciplinary, civil or criminal actions are taken by the 
DOl and/or appropriate Regulatory Board for any misuse or 
inappropriate accessing of patient data. HlPAA·and all 
confidentiality and disclosure provisions ofCalifornia law 
cover the information contained in this database, which 
includes the.patient's dispensed drug record, including 
drug name; date filled; quantity, strength and number of 
refills; pharmacy name and license number; doctor's name 
and DEA number; and, prescription number. 
In 2008, the Attorney General and the CURES team targeted 
the top 50 doctor shoppers in the state, who averaged mor.e 
than 100 doctor and phannacy visits to collect massive 
quantities of addictive drugs like Valium, Vicodin, and 
Oxycontin. The crackdown led to the. arrest of dozens of 
suspects. 
CURE.S also alerts law enforcement and lice~ed medical 
professionals to signs of illegal drug diversions. In 
2008. the Attorney General and the Simi Valley Police 
Department conducted a drug-trafficking investigation 
which revealed a conspiracy in which stolen identities of 
eight doctors were used to illegally write prescriptions. 
'The drug ring also stole the identities of dozens of 
citizens in order to fill the fraudulent prescriptions, and 
were able to obtain more than 11,000 pills for drugs like 
Oxycontin and Vicodin. In May 2009, the CURES team worked 
with the Ventura County Sheriffs Office to provide 
detectives with the prescribing history of a Burbank doctor 
accused of writing hundreds offraudulent prescriptions. 
Seven of his patients died from prescription-<irug . 
overdoses. 
Following an investigation, that included the 
CURES report of the prescriptions he had written, the 
doctor faced criminal charges, lost his medica1license and 
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surrendered his license to prescribe controlled substances. 
Current funding for CURES 
According to documentation provided by DO], costs oftbe 
CURES program in the current year are funded from the 
following sources: 
$379,432.17 from the General Fund for personnel 
salary and benefits; and 
$296,000 from the Department of Conswner Affairs 
Bo~ds for data qollection, software licenses, and 
department IT functions, ($10,000 - Nursing Board, 
·$92,000 - Phannacy Board, $150,000 - Medical Board, 
$4,000 - Osteopathic Medical Board, and $40,000 ­
Dental Board). 
Additionally, a total of$9,1 02,323 in grant monies have 
been awarded to the CURES program since 2003, as follows: 
Bureau afU. S. Justice Administration: 
$297,7452003 (2003), $350,000 (2004), 4000,000 (2006) 
and $4000,000 (2007), primarily for staff and 
onsultant time. 

The Substance Abuse and Mental Health Services 

Administration: $454,578 (2009). 
CURES has also submitted an application for Bureau of 
Justice Funds for 2010. 
Prior legislation 
SB 734 (Torlakson), Chapter 487, Statutes of2005, 
authorized new tamper-resistant prescription pads and 
permitted online access to CURES, pending the acquisition 
ofprivate fwlding: 
SB 151 (Burton), Chapter 406, Statules of2003, elintinates 
the sunset on the CURES program, eliminates the requirement 
that Schedule IT controlled substances prescriptions be 
written on triplicate forms, adds a requirement that 
Schedule ill controlled substances be included in CURES. 
AB 2655 (Matthews), Chapter 345, Statutes of 2002, extended 
the sunset date of!):te CURES program by five years. 
Permits a licensed health care practitioner to make 
? written request of the DOJ for the history of controlled 
substances dispensed to an individual. and permits DOJ to 
provide the history of controlled substances dispensed to 
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an individual to licensed health care practitioners and 
pharmacists. 
SB 1000 (Johannessen) 2001 would have allowed 0 
practitioner eligible to obtain triplicate prescription 
forms for Schedule D coritrolled substances or aphannacist 
to request the history ofcontrolled substances dispensed 
to an individuaJ under his or her care based on data 
contained in CURES. This bill was vetoed by the Goyernor. 
AB 2018 (Thompson), Chapter 1092, Statutes of2oo0, revised 
prescription requirements for _Schedule ncontrolled 
substances by permitting practitioners to receive more than 
100 triplicate prescription blanks in • 30-doj period as 
we1l as other changes. 
SB 1308 (Committee on Business and Professions), Chapter 
655, Statutes of 1999, extended the CURES pilot project by 
three years and requires DOJ to snbmit annual status 
reports on the program to the Legislature. 
AB 2693 (Migden), Chapter 789, Statutes of 1998, exempts 
prescriptions foi Schedule II contro1led substances for 
patients with aterminal illness from triplicate 

prescription form requirements in existing law. 

AB 3042 (Takasugi), Chapter 738, Statutes ofl996, required 
DOJ, contingent on the availability of funds, to establish 
CURES for electronic monitoring of the prescribing and 
dispensing of Schedule n controlled substances by 011 
practitioners authorized to prescribe or dispense these 
qontralled substances as a three-year pilot program. 
An act to amend Section 11165 of, and to add and repeaJ Section 
I Jl65.05 of, the Health and Safety Code, and to add and repeal SeCtion 
17054.8 of, and to add and repeal Part 33 (commencing with Section 
70001) ofDivision 2 of, the Revenue and Taxation Code, relating to 
prescription drugs t8xation, to take effect immediately. tax levy. . 
Existing law imposes various taxes, including taxes on the privilege . 

of engaging in certain .activities. The Fee Collection Procedures Law, 

. the violation ofwhich is a crime, provides procedures for the collection 

ofcertain fees and surcharges. . 
Page 8 
Existing law also requires the Department 
of Justice to maintain the Controlled Substance Utilization Review and 
Evaluation System (CURES) for the electronic monitoring of the 
prescribing and dispensing of Schedule n, Schedule ill, and Schedule 
IV controlled substance$ by all practitioners authorized to prescribe or 
dispense these controlled substances. 
This Proposition would, on and after JanuarY 1.. 2.013, impose a tax at the 
rate of $0.0025 per pill included in 
Schedu1~ II, IiI, or IV upon every manufacturer and importer of controlled 
substances classified as Schedule II. m. or IV, or other person that 
makes the first sale in this state of a Schedule II, m, orTV controlled 
substance. The uix would be administered by the State Board of 
Equalization and would be collected pursuant to the procedures set forth 
in the Fee Collection Procedures Law. 
The Proposition would requiie the board to deposit all taxes, penalties. and 
interest collected, less refunds and administrative costs, in the CURES 
Fund., which this Proposition would create. This PropositioD would require moneys in 
.the fund, upon appropriation by the Legislature, to be ailocated to the 
Department ofJustice for the cost ofadministration of the CURES 
program, as specified. 
This Proposition would also require a person that manufactures co,ntrolled 
substances classified in Schedule II, m. or IV in this state, or that 
imports controlled substances classified in Schedule II. m, or N into 
this state, to register ·with the Department ofJustice to enable the 
department to report specified information to the board for purposes of 
collecting a tax on those persons. 
Because this Proposition would expand the application of the Fee Collection 
Procedures Law, the violation of which is a crime, it would impose a 
state-mandated local program: 
The California Constitution requires the state. to reimburse local 
agencies and school districts for certain costs mandated by the state. 
Statutory provisions establish procedures for making that r.eimbursement. 
This Proposition would provide that no reimbursement is ~quired by this act 
for a specified reason. 
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This proposition would take effect immediately as a tax levy. 
1 we find: 
2 following examination: 

3 (a) The CURES program is a valuable investigative, preventive, 

4 and educational tool for law enforcement, regulatory boards, 

educational researchers, and the health care community. 

6 (b) Each year the CURES program responds to more than 60,000 
7 requests from practitioners and phannacists to (1) help identify 

8 and deter drug abuse and diversion through atcurate and rapid 

9 tracking of Schedule n, ill, and IV controlled substances, (2) help 

practitioners make better prescribing. decisions, and (3) cut down 





13 (c) The manufacture and importation of Schedules n, ill, and 

14 IV controlled substances have had deleterious effects on private 
and public interests, includlng the misuse, abuse, and trafficking 
16 in dangerous prescription medications resulting in injury and death. 
17 The tax that is imposed by this bill on manufacturers and importers . 
18 of Schedules ll, ill, and !V.controlled substances seeks to mitigate 
19 these effects of the drugs by supporting the operation of the 
CURES program, which has proved a cost..etfective tool to help 
21 to reduce the misuse, abuse, and trafficking of t)lose drugs. 

22 (d) It is the nature of these Schedule n, ill, and IV controlled 

23 substances that their addictive qualities and the ever present market 
24 for their misuse and abuse pose inherent risks to public health that 
mUst be systematically addressed, as by the CURES program. 
26 Once these products are present in California, ad hoc enforcement 
27 of conditions on distribution and criminal and civil sanctions on 
28 downstream actors in the distribution system are extraordinarily 
29 co.,tly. ineffective, and inefficient means, to attempt to control the 
misuse, abuse, and trafficking ofthese substances. It is therefore 
31 appropriate for manufacturers and importers, which benefit from 
32 the commercial markets for these inherently dangerous products 

33 with knowledge of their potential'for misuse and abuse absent 

34 systematic tracking and monitoring, to pay for the cost-effective 

CURES program. . 

36 SEC. 2. Section 11165 of the Hcalth and Safety Code is 

11165. (a) To assist law enforcement and regulatory agencies 

in their efforts to control the diversion and resultant abuse of 

Schedule n, Schedule ill, and Schedule IV controlled substances, 
and for statistical analysis, education, and research, the Department 
. of Justice shilll, contingent upon the availability of adequate funds . 
fr9ID the CURES Fund and from the Contingent Fund of the 
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Medical Board of California, the Phamiacy Board Contingent 
Fund, the State Dentistry Fund, the Board of Registered Nursing 
Fund, and the Osteopathic Medical Board of California Contingent 
Fund, maintain the Controlled Substance Utilization Review and 
Evaluation System (CURES) for the electronic monitoring of the 
prescribing and dispensing of Schedule IT, Schedule ill, and . 
Schedule IV controlled substances by all practitioners authorized ' 
to prescribe or dispense these controlled substances. . 
(b) The reporting of Schedule ill and Schedule IV controlled 
substance prescriptions to CURES shall be contingent upon the 
availability of adequate funds D:om the Department ofJustice. The 
Department of Justice may seek and use grant funds to pay the 
costs inc~ from the"reporting of controlled substance 
prescriptions to CURES. Funds shall not be appropriated from the 
Contingent Fund of the Medical Board ofCalifornia, the Pharmacy 
Board Contingent Fund, the State Dentistry Fund, the Board of 
Registered Nursing Fund. the Naturopathic Doctor's Fund, or the 
Osteopathic Medical Board of California Contingent Fund to pay 
the costs of reporting Schedule ill and Schedule IV controlled 
substance prescriptions to CURES. . 
(c) CURES shall operate under existing provisions of law to 
safeguard the privacy and confidentiality ofpatients. Data obtained 
from.CURES shall only be provided to appropriate suite, local, 
and fedCral 'personS or public agencies for disciplinary, civil, or 
criminal purposes and to other agencies or entities, as determined . 
by the Department 'of Justice, for the p~se ofed~cating 
practitioners ap.d others in lieu of disciplinary, civil, or criminal 
actions. Data may be provided to public or private entities, as 
approved by the Department ofJustice, for educational, peer 
review. statistical, or research purposes, provided that patient 
information, including any information that may identify the 
patient, is not cotI?-promised. Further, data disclosed to any 
individual or agency as described in this ~ubdivision shall not be 
disclosed, sold, or transferred to any third party. 
(d) For each prescription for a Schedule II, Schedule ill, or 
Schedule IV controlled substance, the dispensing pharmacy or 
clinic shall provide the following information to the Department 
ofJustice on a weekly basis and in a format specified by the 
Department ofJustice: 
(1) The full name, address, and telephone number of the ultimate. 
user or research subject, or contact information as detennined by 
the Secretary of the United Staies Department ofHealth and Human 
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, Services, and the gender and date ofbirth of the ultimate user. 
(2) The prescriber's category of licensure and license number; 
federal controlled substance registration number; and the state 
medical license number ofany prescriber using"the federal 
controlled substance registration number of a government-exempt 
facility. . 
(3) Pharmacy prescription number, license number, and federal 

controlled substance.registration number. 

(4) NDC (National Drug Code) number of the controlled 
substance dispensed. 
(5) Quantity ofthe controlled substance dispensed. 
(6) ICD-9 (diagnosis code), ifavailable. 
(7) Number of refills ordered. 
(8) Whether the drug was dispensed as a refill ofa prescription 

or as afirst-time request. " 

(9) Date of origin ofthe prescription. 
(10) Date ofdispensing of the prescription. 

SEC. 3. Section 11165.05 is added to the Health aod Safety 

Code, to read: 

11165.05. (a) A person that mannfactures controlled substaoces 

classified in Schedule II, Ill, or IV in this state, or that imports 

controlled substances classified in Schedule n, m, 'Of N into this 
state, shall register with the Department ofJustice to enable the 
department to report to the State Board ofEqualization the persons 
subject to this section and to the tax imposed pursuant to Part 33 
(commencing with Section 70001) ofDivision 2 of the Revenue 
and Taxation Code. 
(b) Aperson shall not sell or distribute any controlled substance 
·classified in Schedule n, III, or IV in the state if the product is 
received or purchased from a manufacrurer or importer that is not 
registered in accordance with'the requirements of this section. 
(b) A person required to register with the department sball file 
an annual report with the department. The annual report shall be 
due on or before January 1,2013, and on or before January 1 each 
year thereafter, and shall provide the name, address, and telephone 
number ofthe person required to register. 
(d) 
"(c) Aperson'.required to register with the department shall also 
file aquarterly report with the department. The quarterly report 
shall be due.on the last day oftbe month following eacb quarterly 
period and shall provide all of the following infonnation: 
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: 
(1) The number of Schedule IT, m, or IV pills the registrant bas 

sold in this state during that quarterly reporting period. 

(2) The number of Schedule IT, Ill, or IV pills the registrant bas 

imported into this state during that quarterly reporting periOd. 

(3) The number of Schedule IT, m,"or IV pills the registrant has 
sold, transferred, or otherwise furnished to other persons in this 
state during that quarterly reporting period. 
(4) Any other information the department deems necessary for 
the purpose of administering this section. 
(e) 
(d) Each registrant that is required to provide the information 
required by this section may be subject to audit by the department. 
(f) 
(e) On the last. day of each month foJlowing the due date for 
filing a quarterly report pursuant to subdivision (d), the department 
shaJl send to the state Board ofEquaJization a report containing 
all of the following information: 
(1) The name, address, and telephone number of each person 
required to register with the department pursuant to this section, 
and the necessary information regarding who OW~ the tax imposed,' 
pursuant to Part 33 (commeocing with Section 70001) ofDivision 

2 of the Revenue and Taxation Code on each Schedule IT, Ill, or 

IV pill sold in this state in the amount of $0.0025 per pill for the 

previous quarterly period. 
(2) The number of Scbedule IT, m, or IV pills each registrant 
.manufactured in this state or imported into this state. 
CONTROLLED SUBSTANCES TAX LAW . 
70001. This part shaJl be lmown and may be cited as the 

ControJled Substances Tax Law. 

70002. For purposes oftbis part: 
(a) "CURES program" means the ControUed Substance 
Utilization Review and Evaluation System program described in 
Section 11 I65 of the Health and Safety Code. 
(b) "Importer" means a person "that imports controJled substances 

classified in Schedule II, m, or IV into this state,. for sale or 

distribution in this state. 
(c) "Manufacturer" means a person that manufactures controlled 
substances clas;ified in Schedule II, m, or IV sold in this state, 
either directly or indirectly. 
(d) "Quarterly report" means the report that a registrant is 
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required to file with the Department ofJustice pw-suant to Section . 
11165.05 of the Health and Safety Code. 
Ce) "Registrant1' means a maqufacturer or importer ofcontrolled 
substances classified in Schedule II, III, or IV that is required to 
annually register and report certairi. information to the Department 
of Justice pursuant to Section 11165.05 of the Health and Safety 
Code. 
70003. On and after January 1,2013, a tax is hereby imposed 
at the rate of$0.0025 per pill included in Schedule II, m, or IV 
upon e~exy manufacturer and importer of controlled substances 
classified as Schedule II, m, or N, or other person that makes the 
first sale in this state of a Schedule II, m, or IV controlled 
substance. The tax imposed by this part is for the purpose of 
reimbursing the Department of Justice for the cost ofadministering 
the CURES program, which provides for the electronic monitoring 
of the prescribing and dispensing ofcontrolled substances classified 
in Schedule II, m, or IV. 
70004. The board shall administer and collect the tax imposed 
by this part ptirsuant to 'the Fee Collection Procedures Law (part 
30 (commencing with Section 55001)). For purposes of this part, 
the references in the Fee Collection Procedures Law to "fee" shall 
include the tax imposed by this part and references to "feepayer" 
shall include a persnn required to pay the tax imposed by this part. 
70005. Each persnn required to pay the tax shall prepare and 
file with the board a return in the form prescribed by the board 
containing infonnation as the board deems necessary or appropriate 
for the proper administration ofthis part. The return shall be filed 
. on or before the last day of the calendar mC?nth·following the 
calendar quarter to which it relates, together with a remittance 
payable to the boam for the amount of tax due for that period. 
70006. The board may prescribe those forms and reporring 
requirements as are necessary to implement the tax, including, but 

Dot limited to, information regarding the total amount·oftax due. 

70007. (a) (I) The CURES Fund is hereby created in the State 
Treasury. The CURES Fund shall consist of all taxes, interest, 
penalties, and other amounts collected pursuant to this·part, less 
refunds and reimbursement to the board for expenses incurred in 
the adrilinistration and collection ofthe tax. 
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(2) Money in the CURES Fund shall, upon appropriation by the 
Legislature, be used to reimburse the Franchise Tax Board for 
administrative costs related to Section 17054.8. . 
(b) All moneys in the CURES Fund less refunds and 
reimbursement pursuant to subdivision (a), shall, ,upon 
appropriation by the Legislature, be allocated to the Department 
ofJustice for the following; 
(I ) The cost of the administration of the CURES program as 
required by this section and Section 11165.050ftIie Health and 
Safety Code. . 
(2) The· cost of the maintenance of, and any improvements to, 
the CURES program. . . 









70008. This part shall remain in effeci only until January I, 

2016, and as of that date is repealed . 

.sEC. 6. No reimbursement is required by this act pursuant to 

Section '6 ofArticle XIllB of the California Constitution because 

the.only costs that may be incurred by a loeal agency or school 

district will be incuITed because this act creates a new crime.or 
infractio~ eliminates' a e:rime or ~ction, or changes the penalty 
for a crime or infraction, within the m~g ofSection 17556 of 
the Government Code, or changes the d~finition ofa crlme .within 
the meaning of Section 6 ofArticle xm B ofthe California 
Constitution. 
SEC. 7, This Proposition provides for a tax levy within the meaning of 
A,rticle N ofthe Constitution and shaH ,go into immediate effect. 
### 
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